April 2021 FDA Recall Drug by Preferred Pharmaceuticals, Inc.
D-0385-2021 - CMGP Deviations

This Class II drug recall was voluntarily initiated by Preferred Pharmaceuticals, Inc. on April 28, 2021 for the product Drug. The FDA reported the reason for recall as cmgp deviations. The product was distributed in Distributed to two physician consignees located in FL. and the recall is currently ongoing.

Recall Number: D-0385-2021

Reason for Recall
CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.
Initiated
04-28-2021
Reported
05-26-2021
Quantity
147 bottles (14,700 extended release tablets)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Preferred Pharmaceuticals, Inc.
Distributed to two physician consignees located in FL.
Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only, Pkg Size: 100, Mfg: Time-Cap Labs Inc.; Farmingdale NY, NDC #: 68788-6932-1

Batch or Lot Expiration Information

Lot# Lot Codes: C2520W,Exp.12/31/2021; E0620F, Exp. 12/31/2021; G2020M, Exp. 4/30/2022; G2720A, Exp. 4/30/2022